BORDEAUX, France–(BUSINESS WIRE)–FineHeart S.A., a clinical-stage medtech company developing breakthrough solutions for cardiology, announces the extension of its ISO 13485:2016 certification to cover all processes related to the production of its fully implantable cardiac assist device, the FlowMaker®. Issued following an audit conducted by BSI, an independent notified body of international reference, this certification validates the robustness of the quality management system implemented by
发布者：Dr.Durant，转转请注明出处：https://robotalks.cn/treatment-of-severe-heart-failure-ai-fineheart-reinforces-its-industrial-credentials-and-long-term-strategy-by-adding-manufacturing-to-its-iso-13485-2016-certification/
